EU
SIOX

Emory University’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Emory University’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-19,854
Closed -$1.97M – 48
2016
Q4 		$1.97M Buy
+19,854
New +$2.09M 1.94% 12

Other funds holding SIOX

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IA
IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

Emory University's SIOX Position: Q1 2017 in Review

Emory University sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2017, closing a stake of 19,854 shares — an estimated $1.97M sold.

Emory University first reported a position in SIOX in Q4 2016 and held it in 1 quarter. The position peaked at $1.97M in Q4 2016. 97 funds tracked by Wall St. Rank hold SIOX as of Q1 2017.

  • Emory University reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Emory University sold 19,854 Sio Gene Therapies Inc. Common Stock shares in Q1 2017, an estimated $1.97M.
  • Emory University first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • Emory University's Sio Gene Therapies Inc. Common Stock position peaked at $1.97M in Q4 2016.
  • 97 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2017.

Based on Emory University's 13F filing for Q1 2017, filed 11 May 2017.